Use of regulators and inhibitors of Pim-1, a serine/threonine kinase, for tumour therapy (Review)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of regulators and inhibitors of Pim-1, a serine/threonine kinase, for tumour therapy (Review)

Published:2014-04-11 Issue:6 Volume:9 Page:2051-2060
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:en
Short-container-title:

Author:

LIANG CHEN,LI YING-YI

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3D chromatin architecture, BRD4, and Mediator have distinct roles in regulating genome-wide transcriptional bursting and gene network;Science Advances;2024-08-09

2. A review on structure-function mechanism and signaling pathway of serine/threonine protein PIM kinases as a therapeutic target;International Journal of Biological Macromolecules;2024-06

3. Pim Kinases: Important Regulators of Cardiovascular Disease;International Journal of Molecular Sciences;2023-07-18

4. Discovery of PIM-1 kinase inhibitors based on the 2,5-disubstituted 1,3,4-oxadiazole scaffold against prostate cancer: Design, synthesis, in vitro and in vivo cytotoxicity investigation;European Journal of Medicinal Chemistry;2023-03

5. New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation;Molecules;2021-02-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP